Matthew J. Espe - Dec 24, 2023 Form 4 Insider Report for DIEBOLD NIXDORF, Inc (DBD)

Role
Director
Signature
/s/ Elizabeth C. Radigan, Attorney-in-fact for Matthew J. Espe
Stock symbol
DBD
Transactions as of
Dec 24, 2023
Transactions value $
$0
Form type
4
Date filed
12/26/2023, 12:30 PM
Previous filing
Oct 3, 2023
Next filing
Jan 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DBD Common Stock Award $0 +40K $0.00 40K Dec 24, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DBD Director Stock Option (right to buy) Award $0 +80K $0.00 80K Dec 24, 2023 Common Stock 80K $30.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted under the Diebold Nixdorf, Incorporated 2023 Equity and Incentive Plan, as amended; option is generally exercisable in substantially equal installments on each of the first four anniversaries of September 22, 2023.